UnitedHealth Group (UNH) Increases Despite Market Slip: Here's What You Need to Know

18.03.25 22:50 Uhr

Werte in diesem Artikel
Aktien

511,00 EUR -20,50 EUR -3,86%

Indizes

PKT PKT

40.524,8 PKT 312,1 PKT 0,78%

15.874,6 PKT 232,9 PKT 1,49%

2.619,3 PKT 16,3 PKT 0,63%

5.406,0 PKT 42,6 PKT 0,79%

In the latest trading session, UnitedHealth Group (UNH) closed at $503.80, marking a +0.96% move from the previous day. This move outpaced the S&P 500's daily loss of 1.07%. Elsewhere, the Dow lost 0.62%, while the tech-heavy Nasdaq lost 1.71%.Heading into today, shares of the largest U.S. health insurer had lost 4.68% over the past month, lagging the Medical sector's gain of 0.53% and outpacing the S&P 500's loss of 7.03% in that time.The investment community will be closely monitoring the performance of UnitedHealth Group in its forthcoming earnings report. It is anticipated that the company will report an EPS of $7.24, marking a 4.78% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $111.01 billion, indicating a 11.24% growth compared to the corresponding quarter of the prior year.For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $29.54 per share and a revenue of $451.2 billion, representing changes of +6.8% and +12.72%, respectively, from the prior year.It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. UnitedHealth Group currently has a Zacks Rank of #3 (Hold).With respect to valuation, UnitedHealth Group is currently being traded at a Forward P/E ratio of 16.89. Its industry sports an average Forward P/E of 15.06, so one might conclude that UnitedHealth Group is trading at a premium comparatively.One should further note that UNH currently holds a PEG ratio of 1.36. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - HMOs industry currently had an average PEG ratio of 1.1 as of yesterday's close.The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 185, positioning it in the bottom 27% of all 250+ industries.The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: UnitedHealth und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf UnitedHealth

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf UnitedHealth

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu UnitedHealth Inc.

Wer­bung

Analysen zu UnitedHealth Inc.

DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
09.11.2016UnitedHealth Group NeutralMizuho
31.03.2011UnitedHealth Group performOppenheimer & Co. Inc.
08.02.2011UnitedHealth Group neutralGoldman Sachs Group Inc.
15.11.2010UnitedHealth Group holdStifel, Nicolaus & Co., Inc.
20.04.2010UnitedHealth neutralWedbush Morgan Securities Inc.
DatumRatingAnalyst
11.06.2009UnitedHealth underperformOppenheimer & Co. Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UnitedHealth Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen